Correvio Pharma Corp (CORV) Return on Investment ROI from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Correvio Pharma Corp   (CORV)


Correvio Pharma's ROI from its fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Correvio Pharma's ROI in the fourth quarter of 2019?
Correvio Pharma Corp recorded a cumulative net loss of $-35 million during 12 months ending in the fourth quarter of 2019, resulting in a negative return on investment (ROI) of -109.76%.

Within the Healthcare sector 649 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2019 from 0 to 4742.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Investment Change TTM -36.19 % -36.58 % -28.75 % -21.52 % -14.83 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 45 28 28 28 50
Return On Investment (TTM) -109.76 % -49.81 % -42.58 % -37.19 % -33 %
CORV's Overall Ranking # 4742 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -3.69 % -14.51 % -12.67 % -11.25 % -4.27 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -35 -17 -17 -17 -17

CORV Company Profile >> Back to CORV Roi Comparisons >> See Annual CORV Return On Investment



Return On Investment CORV's Ranking
Within: No.
Industry # 317
Sector # 650
Overall # 4742

Return On Investment Statistics
High Average Low
20.42 %
-61.63 %
-217.36 %
(Dec 31 2013)   (Dec 31 2012)







Financial Statements
Correvio Pharma's IV. Quarter Investments $ 45 Millions CORV's Balance sheet
Correvio Pharma's IV. Quarter Income $ -35 Millions Quarterly CORV's Income Statement
CORV's Income by Division See CORV's Income by Division


CORV Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 45 50 59 56 32
Y / Y Investment Growth -9.78 % -14.72 % 5.11 % 74.14 % 10.44 %
Net Income in Millions -35 -17 -30 -20 -24
Y / Y Net Income Growth - - - - -
Annual Return On Investment -77.63 % -33 % -50.61 % -35.01 % -76.01 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CORV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CORV's Competitors
Subscribers only: Roi for Correvio Pharma's Suppliers
Subscribers only: Return On Investment for CORV's Customers

Other Ratios
CORV's Roa CORV's Inventory Turnover Ratio CORV's Growth Rates CORV's Dividend Statistics
CORV's Profitability Ratios CORV's Asset Turnover Ratio CORV's Dividend Growth
CORV's Roe CORV's Valuation Ratios CORV's Financial Strength Ratios CORV's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2019, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.